Original articles
-
Congenital tubular aggregates myopathy associated with central nervous system involvement: description of a case
-
The FHL1 myopathy spectrum revisited: a Literature Review and report of two new patients
-
Myotonic Dystrophy type 2 unmasked by physical activity resumption following COVID-19 lockdown: case discussion and review of the literature
-
Abnormal expression of myosin heavy chains in early postnatal stages of spinal muscular atrophy type I at single fibre level
-
Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise
-
Practical recommendations for swallowing and speaking during NIV in people with neuromuscular disorders
-
Indications and techniques of non-invasive ventilation (NIV) in neuromuscular diseases
-
Concise review of end of life and palliative care in neuromuscular pathologies: still a long pathway ahead
-
Nutrition therapy in non-intubated patients with acute respiratory failure: a narrative review
-
Fatigue in Spinal Muscular Atrophy: a fundamental open issue
-
Treatment with ataluren of four symptomatic nmDMD carriers. A pilot study
-
Continuitiy of care with ataluren in Duchenne Muscular Dystrophy patients with nonsense mutations after loss of ambulation. Personal experience
-
Mild limb girdle muscular dystrophy R9 phenotype caused by novel compound heterozygous FKRP gene mutation
-
Skeletal muscle involvement in biallelic SORD mutations: case report and review of the literature
-
The atrial and ventricular myocardial proteome of endstage lamin heart disease
-
Cognitive function in DMD carriers: personal case series and literature review
-
Proposal of a new clinical protocol for evaluating fatigability in adult SMA patients
-
Pregnancy experience in women with spinal muscular atrophy: a case series.
-
Neuromuscular disorders and transition from pediatric to adult care in a multidisciplinary perspective: a narrative review of the scientific evidence and current debate
-
Torin1 restores proliferation rate in Charcot-Marie- Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation
-
Is paravertebral muscles edema a consequence of neurogenic changes in MuSK-positive myasthenia gravis?
-
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM – Italian Muscular Dystrophy Association Workshop report
-
Congenital myopathy associated with a novel mutation in MEGF10 gene, myofibrillar alteration and progressive course
-
Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1
-
The role of BAG3 in dilated cardiomyopathy and its association with Charcot-Marie-Tooth disease type 2
-
Impact of the COVID-19 pandemic on neuromuscular rehabilitation setting. Part 2: patients and families’ views on the received health care during the pandemic
-
Muscle quantitative MRI in adult SMA patients on nusinersen treatment: a longitudinal study
-
Peripheral circulation disturbances in two consecutive children with spinal muscular atrophy and literature review
-
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still “invisible”?
-
Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI
1-30 of 35
Next